ERID-THSTI Summary of Funding Opportunities-Upcoming Deadlines-23Rd Feb 2017 1. RFA-AI-16-079-NIH, NIAID-R01-Partenership for De
Total Page:16
File Type:pdf, Size:1020Kb
Summary of Funding Opportunities-Upcoming deadlines-23rd Feb 2017 1. RFA-AI-16-079-NIH, NIAID-R01-Partenership for Development of Vaccines against M.tb infection/Tuberculosis disease The objective of this FOA is to support milestone-driven research projects focused on establishing proof- of-concept for and/or preclinical development of candidate vaccines against Mtb infection and/or TB. This initiative seeks to facilitate identification of promising lead vaccine candidates and support preclinical development of established leads. For the purpose of this FOA, “candidate vaccine” is defined as a vaccine or related vaccine product (e.g. prime/boost vaccine, therapeutic vaccine, vaccine/adjuvant combinations, etc.); “lead candidate” is defined as a candidate vaccine for which proof-of-concept data have been obtained, and “preclinical development” is defined as all activities beyond lead candidate identification. http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-079.html Due date: March 02nd 2017 2. Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01) Application due dates: January 11, 2018; January 11, 2019 http://grants.nih.gov/grants/guide/pa-files/PAR-16-254.html http://grants.nih.gov/grants/guide/notice-files/NOT-AI-17-003.html (notice on the FOA) The objective of research supported in response to this funding opportunity announcement is to support innovative studies to identify and understand the immunological responses that mediate protection from Mtb infection or progression to active TB disease. Such responses may be operative in mycobacterial infection, or following vaccination with BCG or investigational vaccines. Studies elucidating the differential responses in HIV-infected and HIV-uninfected individuals are of particular interest. Research supported under this funding opportunity announcement should go beyond descriptive information currently known about Mtb infection, immune responses to TB vaccines or immune modulation by non-tuberculous mycobacterial (NTM) infection or by HIV/AIDS. Applications are sought that include characterization of the timing, anatomical location, and contribution to disease outcome of mucosal and/or systemic immune responses to mycobacterial infection and/or vaccination. ERID-THSTI 3. NIH-NIAID-Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antimicrobial-Resistant Gram-Negative Bacteria (R01) The objective of this FOA is to support milestone-driven projects focused on developing and utilizing novel predictive models and/or research tools and assays aimed at gaining a better understanding of the rules and compound properties governing the penetration and efflux of drug-like small molecules into Gram-negative bacterial pathogens. Responsive projects must focus on one or more of the following Gram-negative bacterial pathogens: carbapenem-resistant Enterobacteriaceae (CRE), MDR Acinetobacter and/or MDR Pseudomonas aeruginosa. Projects must complete assay/tool/model development prior to the end of the third year of the project period and initiate discovery activities to demonstrate its utility in supporting a corresponding medicinal chemistry program to generate a lead chemical series with demonstrated activity against one or more targeted Gram-negative bacteria. This initiative will also support subsequent preclinical development of a promising lead antibacterial. http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-16-081.html Due Date: May 17th 2017 4. DBT-Netherlands call for proposals on Technology for a sustainable health care- minimally invasive techniques The aim of the call for proposals is to stimulate sustainable Indian-Dutch research collaboration by funding joint research projects in the area of medical devices that have the explicit goal to contribute to a more sustainable health care either in India or in The Netherlands. The aim is to develop innovative technology for a sustainable healthcare system. We define sustainable healthcare as a high quality system that is affordable and accessible for every individual, and affordable and sufficiently staffed for society as a whole. Three strategic questions to address are: 1. How can technology support health and wellbeing of people in order to help them function and participate in society, outside of organized care? The point is to focus on health rather than healthcare. By focusing on prevention, health and wellbeing you will reduce the need for professional healthcare. 2. How can technology enable care to be delivered closer to home? In many cases it is more cost effective and better for patients to deliver care outside of care institutions. Chronic care should not be managed in hospitals. Rehabilitation should take place closer to home or even at home. 3. How can technology enable more efficient and personalized care? Technology enables us to do more with less. Technology can allow early and individualized diagnosis and prognosis, less invasive treatment and change work processes all together. Besides providing solutions to above questions, an additional goal is to stimulate the Dutch and Indian research fields of medical devices on: Minimally invasive techniques. Proposal deadline: 02nd May 2017 ERID-THSTI 5. The Wellcome Trust/DBT India Alliance and EMBO are looking to fund interdisciplinary meetings that cover the latest developments in research areas underserved in India. These meetings should address discovery and innovation through an interdisciplinary approach, with the speakers and participants discussing important global challenges in the context of the life sciences. Eligibility India | EMBO Symposia must take place in India, but scientists from anywhere in the world are eligible to apply, independent of their nationality. India | EMBO Symposia must cover frontier, pioneering and interdisciplinary areas of life sciences that are underserved in India, and include speakers with interdisciplinary expertise. Furthermore, the application should include a list of (mostly) confirmed speakers. For detailed information on the eligibility criteria, including the format of the meeting, please consult the application guidelines (pdf). For detailed information on the application process, key dates, format of the meeting and required documentation, please consult the application guidelines or visit India | EMBO Symposia website. Application deadlines: 15 February and 15 July 2017 6. Human Frontier Science Program HFSP supports international scientific collaborations. Research Grants are awarded for innovative research projects involving extensive collaboration among teams of independent scientists working in different countries and in different disciplines. Two types of grants are available: Young Investigator Grants for teams where all members are within 5 years of starting their first independent position (and within 10 years of receiving a PhD) and Program Grants for teams of scientists at any stage of their careers. Applicants must first submit a letter of intent via the HFSP extranet. More details are available in the GUIDELINES which you should read before starting an application. The 2018 competition (application in March 2017 for awards to be announced in March 2018) is now open. Guidelines for 2018 Program and Young Investigator applications are now available. Applications will be made via the HFSP extranet website which will be operational from mid-January 2017 onwards. You must initiate an application (with a 2018 reference number) via the website by March 20th, 2017. Submission of Letters of Intent deadline: March 30th, 2017. Guidelines and Application instructions for the letter of intent Documents for Grant management weblink: http://www.hfsp.org/funding/research-grants/information-and-guidelines ERID-THSTI 7. NIH, NICHD-Moving Beyond Standard Assessments: Applying Novel Tools to Assess Human Placental Structure and Function in Real Time Moving Beyond Standard Assessments: Applying Novel Tools to Assess Human Placental Structure and Function in Real Time 1. RFA-HD-18-004, R21 Exploratory/Developmental Grant 2.RFA-HD-18-003, R01 Research Project Grant- Due date: March 31st 2017 Scope of Research to be Performed This FOA is for the development of novel methods for studying the placenta in vivo with the ultimate goal of human use across pregnancy. Special consideration will be given to applications that develop methods that are applicable throughout pregnancy, preferably starting in early gestation during the period of trophoblast invasion and remodeling of the uterine spiral arteries, and which also establish reference values. The placenta is a dynamic organ which changes over the course of pregnancy. To be helpful, assessments need to yield results within a time frame that reflects the current structural/functional status. However, real-time is not meant to imply instantaneous results. 8. VAJRA-visiting advanced joint research faculty scheme-SERB Department of Science and Technology announces launching of VAJRA(Visiting Advanced Joint Research) Faculty scheme which enables NRIs and overseas scientific community to participate and contribute to research and development in India. Public funded academic institutions and national laboratories are eligible to host the VAJRA Faculty. These institutions should appoint them as Adjunct / Visiting Faculty and involve them in co-guiding and mentoring of students and developing collaborative programs. The Faculty can also be allowed to participate